Skip to main content
2024 ISPE Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Evaluation

CV Risk Post-Vaccine Exposure

Monday, August 26, 2024
5:15 PM – 6:45 PM CEST
Location:Conv Hall I C

Presentations:

  • 5:15 PM – 5:30 PM CEST
    A comparison of self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases

    Presenting Author: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine

    Co-Author: Ivonne Martin – 2. Department Data Science & Biostatistics, University Medical Centre Utrecht, the Netherlands

    Co-Author: Davide Messina – ARS Toscana, Florence, Italy

    Co-Author: Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University

    Co-Author: Svetlana V. Belitser – 4. Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands

    Co-Author: Juan José Carreras, PhD, PharmD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain.

    Co-Author: Elisa Correcher-Martinez – 5. Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)

    Co-Author: Arantxa Urchueguía-Fornes, PhD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)

    Co-Author: Mar Martín-Pérez, PharmD, PhD – Spanish Agency of Medicines and Medical Devices (AEMPS)

    Co-Author: Patricia Garcia – Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain

    Co-Author: Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)

    Co-Author: Meritxell Pallejà-Millán – 8. Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)

    Co-Author: Carlo Alberto Bissacco – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)

    Co-Author: Elena Segundo, n/a – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)

    Co-Author: Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University

    Co-Author: Fabio Riefolo, PhD – Teamit Institute, Partnership, Barcelona Health Hub, Barcelona, Spain.

    Co-Author: Carlos E. Durán, MD, PhD – Department of Data Science and Biostatistics, University Medical Center Utrecht

    Co-Author: Rosa Gini, PhD – ARS Toscana, Florence, Italy

    Co-Author: Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands

    Co-Author: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University

    Co-Author: Ian Douglas, PhD, MSc, BSc – London School of Hygiene & Tropical Medicine

  • 5:30 PM – 5:45 PM CEST
    Ad26.COV2.S vaccine and thromboembolic risks among premenopausal women: Exploring variation by combined hormonal medication use

    Presenting Author: Melanie H. Jacobson, PhD, MPH (she/her/hers) – Johnson and Johnson Innovative Medicine

    Co-Author: Joel N. Swerdel, PhD MS MPH (he/him/his) – Johnson and Johnson Innovative Medicine

    Co-Author: Azza Shoaibi, PhD, MPH – Johnson & Johnson

    Co-Author: Kevin Haynes, PharmD, MSCE (he/him/his) – Johnson and Johnson Innovative Medicine

    Co-Author: Luis Humberto Anaya-Velarde, MD, MSc – Johnson & Johnson Innovative Medicine

    Co-Author: E. Claire Newbern, PhD, MPH – Johnson and Johnson Innovative Medicine

  • 5:45 PM – 6:00 PM CEST
    Use of Target Trial Emulation for VHA Drug Safety Evaluations: A Case Study with Bivalent COVID-19 Vaccination and Hospitalizations for Ischemic Stroke

    Presenting Author: Kevin W. Mcconeghy, PharmD, PhD – Veterans Health Administration

    Co-Author: Kwan Hur, PhD – Veterans Health Administration

    Co-Author: Rong Jiang, MS – Veterans Health Administration

    Co-Author: Lucy Pandey, MS – Veterans Health Administration

    Co-Author: Walid Gellad, MD – VA Pittsburgh Healthcare System

    Co-Author: Peter Glassman, MBBS, MSc – Veterans Health Administration

    Co-Author: Chester B. Good, MD, MPH – Veterans Health Administration

    Co-Author: Donald R. Miller, ScD – Veterans Health Administration

    Co-Author: Yinong Young-Xu, ScD, MA, MS – Edward Hines, Jr. Veterans Affairs Hospital, Hines, Illinois, USA

    Co-Author: Fran E. Cunningham, PharmD – Veterans Health Administration

  • 6:00 PM – 6:15 PM CEST
    Stroke Risk Following Receipt of COVID-19 Bivalent Vaccines Among U.S. Adults Aged ≥65 Years

    Presenting Author: Yun Lu, PhD – Center for Biologics Evaluation and Research, Food and Drug Administration

    Co-Author: Kathryn Matuska, BA – Acumen, LLC

    Co-Author: Gita Nadimpalli, MD, MPH, PhD – Acumen, LLC

    Co-Author: Yuxin Ma – Acumen LLC

    Co-Author: Nathan N. Duma, PhD – Acumen LLC

    Co-Author: Henry Zhang – Food and Drug Administration

    Co-Author: Yiyun Chiang, MPH – Acumen LLC

    Co-Author: Hai Lyu – Acumen., LLC

    Co-Author: Yoganand Chillarige, MPA – Acumen LLC

    Co-Author: Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA

    Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA

    Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration

  • 6:15 PM – 6:30 PM CEST
    A Self-Controlled Case Series to Evaluate Risk of Ischemic Stroke Following Bivalent COVID-19 Vaccine Administration in a US Veteran Population

    Co-Author: Kwan Hur, PhD – Veterans Health Administration

    Presenting Author: Kevin W. Mcconeghy, PharmD, PhD – Veterans Health Administration

    Co-Author: Bharat Thakkar, MS – Veterans Health Administration

    Co-Author: Lucy Pandey, MS – Veterans Health Administration

    Co-Author: Walid Gellad, MD – VA Pittsburgh Healthcare System

    Co-Author: Peter Glassman, MBBS, MSc – Veterans Health Administration

    Co-Author: Chester B. Good, MD, MPH – Veterans Health Administration

    Co-Author: Yinong Young-Xu, ScD, MA, MS – Edward Hines, Jr. Veterans Affairs Hospital, Hines, Illinois, USA

    Co-Author: Donald R. Miller, ScD – Veterans Health Administration

    Co-Author: Fran E. Cunningham, PharmD – Veterans Health Administration

  • 6:30 PM – 6:45 PM CEST
    The effect of influenza vaccination on risk of myocardial infarction (MI) in patients taking statins: a self-controlled case series study

    Presenting Author: William E. Henley – University of Exeter

    Co-Author: Adam Streeter – Universität Münster